首页> 美国卫生研究院文献>Disease Markers >HLA-DR Association in Papillary Thyroid Carcinoma
【2h】

HLA-DR Association in Papillary Thyroid Carcinoma

机译:HLA-DR协会在乳头状甲状腺癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Papillary thyroid carcinoma (PTC) is the most frequent types of thyroid malignancies. Several genes may be involved in susceptibility of thyroid cancer including Human Leukocyte Antigens (HLA). The association of thyroid carcinoma with HLA alleles has been previously studied in other populations and certain HLA alleles were shown to be either predisposing or protective. The aim of this study was to determine the association between HLA-DR and papillary thyroid carcinoma in an Iranian population. Design: HLA-DR antigen frequencies were determined in patients with papillary thyroid carcinoma (N = 70) and non-related healthy controls (N=180) using PCR -SSP. Main Outcome: We found that HLA-DRB1*04 frequency was significantly higher in our patients compared to the controls [P = 0.02, OR; 1.9, 95% CI (1.04–3.57)]. Conclusions: Our results revealed HLA-DRB1*04 as predisposing factor in papillary thyroid carcinoma in Iranian population. This confirms the previous findings for associations between HLA-DRB1 and differentiated carcinomas in other populations.
机译:目的:甲状腺乳头状癌(PTC)是最常见的甲状腺恶性肿瘤。几种基因可能与甲状腺癌的易感性有关,包括人类白细胞抗原(HLA)。先前已在其他人群中研究了甲状腺癌与HLA等位基因的关联,并且某些HLA等位基因显示为易感性或保护性。这项研究的目的是确定伊朗人群中HLA-DR与甲状腺乳头状癌之间的关联。设计:使用PCR -SSP测定甲状腺乳头状癌(N = 70)和非相关健康对照(N = 180)患者的HLA-DR抗原频率。主要结果:我们发现,与对照组相比,我们患者的HLA-DRB1 * 04频率显着更高[P = 0.02,或; 1.9,95%CI(1.04-3.57)]。结论:我们的结果显示HLA-DRB1 * 04是伊朗人群甲状腺乳头状癌的诱发因素。这证实了先前关于HLA-DRB1与其他人群中分化癌之间关联的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号